“What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances”: Industry leaders including Virax CEO, James Foster, share their expectations for the year ahead
Article by Eleanor Malone
“Global Launch Strategies in the Current Political Climate”: Virax CEO, James Foster, discusses how global launches are being impacted by changing geopolitical conditions
Article by Mike Hollan
“Lyme Disease: Are we Close to an Effective Diagnostic Test?”: Dr. Nigel McCracken speaks to Clinical Lab Products Magazine
Article by Chris Wolski
“Combating chronic inflammation through immune diagnostics”: Dr. Nigel McCracken speaks to Longevity.Technology
Article by Eleanor Garth
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits with Cosmos Health Inc.
Virax Biolabs to Participate in the 7th European Congress of Immunology 2024
Virax Biolabs are excited to announce our attendance at the 7th European Congress of Immunology (ECI), taking place in Dublin. The Congress runs from 1-4th September, and you can visit our research team at Booth C13. Hosted by the Irish Society for Immunology (ISI) and the European Federation of Immunological Societies (EFIS), this prestigious event gathers over 3,000 immunologists from across Europe and beyond, making it one of the most highly-regarded conferences in the field of basic and clinical immunology. Join us in Dublin and find out more about our current portfolio of T cell assays & immune profiling solutions. We look forward to connecting with fellow attendees and contributing to the dynamic discussions that will shape the future of immunology. Read more here.